Wild-type IDH2 is a therapeutic target for triple-negative breast cancer

Jiangjiang Li(Sun Yat-sen University), Peng Huang(Wildlife Conservation Society)

Nature Communications

April 24, 2024

10.1038/s41467-024-47536-6

Cited by 27

Related Papers

Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance

|Blood|2007|485

Bortezomib Inhibits PKR-Like Endoplasmic Reticulum (ER) Kinase and Induces Apoptosis via ER Stress in Human Pancreatic Cancer Cells

|Cancer Research|2005|324

Bortezomib Sensitizes Pancreatic Cancer Cells to Endoplasmic Reticulum Stress-Mediated Apoptosis

|Cancer Research|2005|307

Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming

|Nature Communications|2020|258

Aggresome Disruption: A Novel Strategy to Enhance Bortezomib-Induced Apoptosis in Pancreatic Cancer Cells

|Cancer Research|2006|242